Intra- and inter-observer variability in measurement of target lesions: implication on response evaluation according to RECIST 1.1.

Background: The assessment of cancer treatment in oncological clinical trials is usually based on serial measurements of tumours' size according to the Response Evaluation Criteria in Solid Tumours (RECIST) guidelines. The aim of our study was to evaluate the variability of measurements of target lesions by readers as well as the impact on response evaluation, workflow and reporting.

Patients And Methods: Twenty oncologic patients were included to the study with CT examinations from thorax to pelvis performed at a 64 slices CT scanner.

Detection of intestinal bleeding with multi-detector row CT in an experimental setup. How many acquisitions are necessary?

The purpose of the study was to evaluate multi-detector computed tomography (MDCT) acquired in different acquisitions (unenhanced, and arterial and portal venous phase following intravenous contrast medium) for detection of intestinal bleeding using an experimental bowel model. The model consisted of an injector tube with a perforation placed in a 7-m-long small bowel of a pig. The bowel was filled with water/contrast medium solution of 30–40 HU and was incorporated in a phantom model.

Evaluation of dual-phase multi-detector-row CT for detection of intestinal bleeding using an experimental bowel model.

To evaluate dual-phase multi-detector-row computed tomography (MDCT) in the detection of intestinal bleeding using an experimental bowel model and varying bleeding velocities. The model consisted of a high pressure injector tube with a single perforation (1 mm) placed in 10-m-long small bowel of a pig. The bowel was filled with water/contrast solution of 30-40 HU and was incorporated in a phantom model containing vegetable oil to simulate mesenteric fat.